Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 10;92(9):e0017524.
doi: 10.1128/iai.00175-24. Epub 2024 Jul 15.

Eosinophils as drivers of bacterial immunomodulation and persistence

Affiliations
Review

Eosinophils as drivers of bacterial immunomodulation and persistence

Katelyn M Parrish et al. Infect Immun. .

Abstract

Traditionally, eosinophils have been linked to parasitic infections and pathological disease states. However, emerging literature has unveiled a more nuanced and intricate role for these cells, demonstrating their key functions in maintaining mucosal homeostasis. Eosinophils exhibit diverse phenotypes and exert multifaceted effects during infections, ranging from promoting pathogen persistence to triggering allergic reactions. Our investigations primarily focus on Bordetella spp., with particular emphasis on Bordetella bronchiseptica, a natural murine pathogen that induces diseases in mice akin to pertussis in humans. Recent findings from our published work have unveiled a striking interaction between B. bronchiseptica and eosinophils, facilitated by the btrS-mediated mechanism. This interaction serves to enhance pathogen persistence while concurrently delaying adaptive immune responses. Notably, this role of eosinophils is only noted in the absence of a functional btrS signaling pathway, indicating that wild-type B. bronchiseptica, and possibly other Bordetella spp., possess such adeptness in manipulating eosinophils that the true function of these cells remains obscured during infection. In this review, we present the mounting evidence pointing toward eosinophils as targets of bacterial exploitation, facilitating pathogen persistence and fostering chronic infections in diverse mucosal sites, including the lungs, gut, and skin. We underscore the pivotal role of the master regulator of Bordetella pathogenesis, the sigma factor BtrS, in orchestrating eosinophil-dependent immunomodulation within the context of pulmonary infection. These putative convergent strategies of targeting eosinophils offer promising avenues for the development of novel therapeutics targeting respiratory and other mucosal pathogens.

Keywords: Bordetella spp.; BtrS; Th17 microenvironment; eosinophils; immune homeostasis; long-term protection; mucosal immunity; mucosal infections; persistence; pertussis; whooping cough.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig 1
Fig 1
Predicted kinetics of the immune responses to RB50 and RB50ΔbtrS. The dotted lines indicate lung bacterial burden (blue shows RB50 and red shows RB50ΔbtrS). Immune cell recruitment to the lungs is shown in green (neutrophils), magenta (macrophages), black (eosinophils), yellow (T cells), and lilac (B cells). Relative numbers are indicated in the Y-axis, while days post-infection are shown in the X-axis.
Fig 2
Fig 2
Multifaced roles of eosinophils. Eosinophils can be considered into two categories, more anti-inflammatory phenotype (blue) associated with bacterial persistence or more pro-inflammatory (red) where eosinophils actively contribute to bacterial killing during infection.
Fig 3
Fig 3
Predicted role of eosinophils during Bordetella spp. infections. Bordetella spp. secrete “Bordetella eosinophil factors” that will suppress eosinophil effector function leading to persistence. Deletion of the bacterial sigma factor btrS results in no suppression of eosinophils. In this context, eosinophils promote adaptive immune responses, formation of germinal centers in the lungs, and rapid clearance of infection.

Similar articles

Cited by

  • Highlights of the 14th International Bordetella Symposium.
    Munoz Navarrete K, Edwards KM, Mills KHG, Kamanová J, Rodriguez ME, Gorringe A, Preston A, Kampmann B, Gestal MC, Harvill ET, Dubey P, Diavatopoulos DA, Mattoo S, Scanlon KM, Locht C, Sebo P. Munoz Navarrete K, et al. mSphere. 2025 Jun 25;10(6):e0018925. doi: 10.1128/msphere.00189-25. Epub 2025 May 16. mSphere. 2025. PMID: 40377335 Free PMC article. Review.

References

    1. Ahmad JN, Sebo P. 2020. Adenylate cyclase toxin tinkering with monocyte-macrophage differentiation. Front Immunol 11:2181. doi:10.3389/fimmu.2020.02181 - DOI - PMC - PubMed
    1. Petráčková D, Farman MR, Amman F, Linhartová I, Dienstbier A, Kumar D, Držmíšek J, Hofacker I, Rodriguez ME, Večerek B. 2020. Transcriptional profiling of human macrophages during infection with Bordetella pertussis. RNA Biol 17:731–742. doi:10.1080/15476286.2020.1727694 - DOI - PMC - PubMed
    1. Valdez HA, Oviedo JM, Gorgojo JP, Lamberti Y, Rodriguez ME. 2016. Bordetella pertussis modulates human macrophage defense gene expression. Pathog Dis 74:ftw073. doi:10.1093/femspd/ftw073 - DOI - PubMed
    1. Hewlett EL, Donato GM, Gray MC. 2006. Macrophage cytotoxicity produced by adenylate cyclase toxin from Bordetella pertussis: more than just making cyclic AMP! Mol Microbiol 59:447–459. doi:10.1111/j.1365-2958.2005.04958.x - DOI - PubMed
    1. Siciliano NA, Skinner JA, Yuk MH. 2006. Bordetella bronchiseptica modulates macrophage phenotype leading to the inhibition of CD4+ T cell proliferation and the initiation of a Th17 immune response. J Immunol 177:7131–7138. doi:10.4049/jimmunol.177.10.7131 - DOI - PubMed

Publication types

LinkOut - more resources